However, treatment was also linked with an increased risk of complications such as preterm delivery, gestational diabetes, and pre-eclampsia.
Thyroid hormone treatment was associated with decreased risk of pregnancy loss among women with subclinical hypothyroidism, especially those with pre-treatment TSH concentrations of 4.1-10 mIU/L.
This example is same.